Add Row

Add Element

update

My Wellness Train Network

update

Add Element

Menu 1
Menu 2
Menu 3
Menu 4
Menu 5
Menu 6

Add Element

update
update
update
update
update
update
update

April 27.2025

2 Minutes Read

FDA Warns: Finasteride Side Effects Could Impact Mental Health

Finasteride side effects: man applying spray on scalp.

The FDA's Crucial Warning on Finasteride: What You Need to Know

The Food and Drug Administration (FDA) has raised significant concerns regarding the compounded topical version of finasteride—a popular hair loss treatment marketed by telehealth platforms such as Hims & Hers and Ro. This warning, issued on April 22, 2025, highlights troubling reports of adverse side effects, including depression, dizziness, and decreased libido, among male users.

Critical Risks and Missing Information

A total of 32 cases of adverse reactions linked to topical finasteride were reported from 2019 to 2024. Alarmingly, many individuals who experienced these side effects often claimed they were not properly informed about the potential risks associated with the drug. Unlike traditional pharmaceutical companies, telehealth platforms are not strictly regulated, exposing consumers to unmonitored formulations and a lack of transparency regarding side effects.

Understanding the Side Effects

The side effects reported by users align closely with those linked to the oral form of finasteride, which has been FDA-approved for years. Users have reported serious symptoms that have impacted their mental health and overall quality of life, with some stating that their physical side effects led to an overwhelming sense of despair. According to Dr. Anthony Oro, a dermatologist at Stanford Medicine, these reactions are to be expected, but the lack of adequate consumer education is concerning.

Importance of Informed Decision-Making

The FDA's warning serves as a crucial reminder for consumers considering hair loss treatments through telehealth channels. It underscores the importance of understanding the potential risks and benefits of any medication. For those seeking treatment for hair loss or exploring various options like finasteride, it is essential to consult healthcare professionals who can provide comprehensive and medically approved information.

Taking Action: What You Should Do

If you or someone you know is using topical finasteride or considering it as a treatment option, it is vital to stay informed and cautious. Speak with your healthcare provider if you have concerns, and always read the fine print regarding side effects. If you need more personalized advice or support in navigating health and wellness decisions, contact us today at 984-238-6164 or via email at tom@mywellnesstrain.com.

Men's Wellness

53 Views

0 Comments

Write A Comment

Related Posts All Posts

01.19.2026

FDA Expert Panel Calls for Expanded Access to Testosterone Replacement Therapy

Update FDA Panel's Bold Move: Expanding Access to Testosterone Replacement Therapy A recent meeting of an FDA expert panel has sparked conversations about the future of testosterone replacement therapy (TRT) in the United States. With growing evidence challenging the longstanding restrictions surrounding TRT, the panel is passionately advocating for expanded access for men nationwide. As they pushed for a reevaluation of TRT’s restrictive regulations, they highlighted the public health imperative behind their recommendations. Understanding the Current Landscape of TRT Festering underutilization has led many to question current FDA restrictions on TRT, which is only approved for specific medical conditions such as testicular dysfunction and pituitary disorders. Experts argue that this narrow view does not account for age-related testosterone deficiency—a growing concern as lifestyle-related health challenges rise. Renowned urologist Dr. Helen L. Bernie asserts, "If we want to close the mortality gap amongst men, we must recognize testosterone deficiency as a public health issue." This sentiment echoes across the panel, signaling a shift in understanding testosterone’s role in male health. Reassessing the Risks and Benefits of TRT Historically, concerns regarding TRT linked it to increased risks of cardiovascular diseases and prostate cancer. However, recent substantial clinical trials have found these risks either minimal or unfounded, leading to renewed support from the panel for the therapy. Notably, the TRAVERSE trial debunked the cardiovascular stress often associated with TRT, showing no significant difference in heart attack or stroke incidents compared to placebo in men with hypogonadism. A Future with Broader Indications? The FDA panel’s readiness to expand the approved indications for TRT may unfold a new chapter in men’s health. They recommend that the agency consider testosterone therapy for age-related low testosterone, recognizing that many men face hormonal challenges due to sedentary lifestyles and growing obesity rates. This expansion would align the FDA’s stance more closely with guidelines from organizations like the American Urological Association, which advocate for broader applications of TRT. Revisiting Testosterone’s Controlled Substance Classification Another pivotal recommendation from the FDA panel is the declassification of testosterone from Schedule III controlled substances. Current classifications hinder accessibility and treatment consistency among healthcare providers. Experts believe that this change could facilitate proper therapy channels, ensuring that men receive testosterone through qualified specialists rather than questionable clinics. Dr. Franck Mauvais-Jarvis emphasized, "Removing testosterone's Schedule III status can empower providers to prescribe it with confidence and encourage patients to seek appropriate treatment." However, not all experts share this perspective; there are concerns that easier access could lead to misuse without proper guidance. Next Steps in Men’s Health The future of TRT may very well hinge on the FDA's willingness to heed the panel's recommendations. In a climate where men's health issues often take a backseat, these developments offer new hope for many. If adopted, these changes could revolutionize how testosterone deficiency is perceived and treated. As we wait for regulatory updates, awareness and appropriate discussions about TRT will be vital for men seeking to enhance their health and longevity. To navigate the complexities of TRT, individuals must seek professional medical advice tailored to their unique health needs. If you're curious about how TRT could benefit your health journey, call us today at 984-238-6164 or email us at tom@mywellnesstrain.com.

10.23.2025

Investigating Prostate Cancer: How Enzalutamide Lowers Death Risk by Over 40%

Update The Breakthrough in Prostate Cancer TreatmentProstate cancer, a leading cause of cancer-related mortality among men globally, has seen a significant breakthrough with the introduction of enzalutamide in combination with leuprolide. Recent studies indicate that this drug combination not only enhances survival rates in patients but also changes the approach to treatment timing, potentially allowing for a more aggressive intervention during the early stages of biochemically recurrent disease.What the Research RevealedAccording to findings shared during the European Society for Medical Oncology (ESMO) Congress, the combination therapy significantly reduces the risk of death among high-risk prostate cancer patients. Specifically, the phase 3 EMBARK trial found that pairing enzalutamide, an androgen receptor blocker, with leuprolide, a hormone therapy, leads to an almost 40% lower risk of mortality in men whose cancer recurred after initial treatment with surgery or radiation. The overall survival rate after eight years for those on the combined therapy was 78.9%, compared to just 69.5% for those receiving leuprolide alone.Understanding Prostate Cancer RecurrenceFor many patients, the journey with prostate cancer is fraught with uncertainty, especially when the cancer returns after what was believed to be successful primary treatment. The presence of rapidly rising prostate-specific antigen (PSA) levels often signifies a higher risk of metastasis. In fact, experts stress that the shorter the time it takes for PSA levels to double, the more aggressive the disease likely is. Thus, the new findings about enzalutamide combined with leuprolide provide a glimmer of hope.Clinical Implications and Patient OutcomesThis combination is now showing promise as a new standard of care in managing high-risk recurrent prostate cancer. It is crucial for both patients and healthcare providers to weigh the potential benefits against possible treatment side effects, as aggressive treatment approaches can sometimes lead to overtreatment and a range of adverse effects. The study found that while serious adverse effects were slightly higher in patients taking enzalutamide, they remained under 10% for the majority.Future DirectionsThe implications of this research extend beyond just numbers; they paint a picture of a future where early and proactive treatment strategies can significantly impact survival. As research continues to unfold, it could pave the way for personalized medicine approaches tailored to individual patient profiles by taking into account the aggressiveness of their cancer.Make Informed Health ChoicesUnderstanding new treatment options can be empowering for patients and their families. If you or a loved one is navigating prostate cancer treatment, consider discussing these findings with your healthcare provider to see if this new therapy could be the right option for you.

09.08.2025

Prostate Cancer Cases Rise After Decade of Decline: What You Need to Know

Update Prostate Cancer Cases on the Rise: An Alarming Trend The recent surge in prostate cancer diagnoses is raising red flags across the medical community. After witnessing a steady decline over the past few decades, prostate cancer rates have reversed course, displaying a concerning annual increase of 3% from 2014 to 2021. This news comes amid alarming statistics from the American Cancer Society (ACS) predicting 313,780 new cases and 35,770 deaths in 2025 alone. The growth in diagnoses is particularly troublesome as it is largely driven by advanced cases, often diagnosed in men as young as 55, significantly increasing the urgency for proactive screening and detection strategies. Understanding the Implications of Late-Stage Diagnoses Late-stage prostate cancer cases—instances where cancer has metastasized to other areas of the body—have seen increases as high as 6.2% each year. Mortality rates, while once declining, have decelerated to a meager 0.6% reduction annually over the past decade. This trend begs the question: Are our current screening recommendations adequate to combat this deadly disease? The Role of PSA Screening in Prostate Cancer Detection Eyebrows are raised regarding the recommendations set by the U.S. Preventive Services Task Force (USPSTF), which downgraded PSA screenings to a “D” score for men over 70 in the early 2010s. For men ages 55-59, the guidelines remain a “C,” suggesting that periodic screening may be considered. Medical professionals are increasingly advocating for a reevaluation of these recommendations to mitigate the alarming trends in late-stage diagnoses. Empowering Men's Health: The Importance of Early Detection and Awareness The increasing rate of prostate cancer reflects a broader issue of men's health awareness. Proactive approaches, like regular health screenings and discussions about symptoms with healthcare providers, are crucial in early detection. Men's health is often shrouded in stigma, but understanding one's risks can significantly impact outcomes. Encouraging men to take charge of their health through educated conversations and timely screenings can lead to earlier interventions and better prognosis. What You Can Do: Proactive Steps for Healthier Living To combat the rising rates of prostate cancer and to foster a culture of health and wellness, consider incorporating lifestyle adjustments that prioritize health. This includes a balanced diet, physical activity, and regular medical check-ups. Chronic illnesses, such as type 2 diabetes or heart disease, can compound risks for cancer, emphasizing the necessity of holistic health management. Consider reaching out for mental health support if you feel overwhelmed, as emotional well-being is an essential component of overall health. For more personalized advice, call us today at 984-238-6164 or email us at tom@mywellnesstrain.com for comprehensive wellness support and guidance.

FDA Warns: Finasteride Side Effects Could Impact Mental Health

The FDA's Crucial Warning on Finasteride: What You Need to Know

Critical Risks and Missing Information

Understanding the Side Effects

Importance of Informed Decision-Making

Taking Action: What You Should Do

Terms of Service

Privacy Policy

Core Modal Title